28 January 2026 : Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkish Oncology Centers
Halil Göksel Güzel
ABCDEF 1*, Arif Hakan Önder ABDEF 1, Yusuf İlhan BD 2, Onur Yazdan Balçık BD 3, Banu Öztürk ABEF 1
DOI: 10.12659/MSM.951027
Med Sci Monit 2026; 32:e951027
Figure 2 Availability of next-generation sequencing (NGS) in hospitals. (A) Comparison between general health insurance (GHI)-based public hospitals and private hospitals.The proportion of NGS availability was comparable between public and private hospitals; P=0.108. (B) Comparison between hospitals in the 3 largest metropolitan areas and hospitals in other cities. The proportion of NGS availability was significantly higher in the 3 largest metropolitan areas than in other cities; P<0.001.